|View printer-friendly version|
|June 24, 2008 3:11 p.m.|
|Teva to Present at The Piper Jaffray Third Annual Europe Conference|
|Jerusalem, Israel, June 24, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Piper Jaffray Third Annual Europe Conference in London. Dan Suesskind, Chief Financial Officer, will present on Wednesday, June 25, 2008. |
What: Teva Presentation at the Piper Jaffray Third Annual Europe Conference
Who: Dan Suesskind, Chief Financial Officer.
When: Wednesday, June 25, 2008 at 9:00 a.m.
Where: www.tevapharm.com or www.piperjaffray.com/europe2008
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.